Poland’s Medical Fund and the Accelerated Reimbursement Mechanism for Orphan and Oncology Drugs in 2021-2025: Small Gains and an Uncertain Future
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
$2995
Four years on from the implementation of the Medical Fund Act, GlobalData takes a look at the impact it has had on the availability of new, innovative therapies in Poland during this period.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
See what our customers are saying
Related reports
View more Product Type reports
New
New
New